Paul Nguyen
Brigham and Women's Hospital

Last Updated On 11/16/2020 2:03:31 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
Company: Volatilyx
Recipient: An Immediate Family Member
Company: Augmenix
Recipient: You

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: GigaGen
Recipient: An Immediate Family Member
Company: Biogen
Recipient: An Immediate Family Member
Company: Medivation
Recipient: You
Company: GenomeDx
Recipient: You
Company: Ferring
Recipient: You
Company: Nanobiotix
Recipient: You
Company: Dendreon
Recipient: You
Company: Augmenix
Recipient: You
Company: Bayer
Recipient: You
Company: Astellas Pharma
Recipient: You
Company: Blue Earth Diagnostics
Recipient: You
Company: Augmenix
Recipient: You
Company: Coda
Recipient: You
Company: Boston Scientific
Recipient: You
Company: Janssen Oncology
Recipient: You
Company: Myovant Sciences
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Wako Diagnostics
Recipient: An Immediate Family Member
Company: Astellas Pharma
Recipient: You
Company: Nanobiotix
Recipient: You
Company: Janssen
Recipient: You
Company: Bayer
Recipient: You

Patents, Royalties, Other Intellectual Property
Please describe: Wife has a patent on volatile diagnostics of infections
Recipient: An Immediate Family Member

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
Company: Ferring
Recipient: You

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
not answered

(OPTIONAL) Open Payments Link
not answered